Navigation Links
Through-the-nipple breast cancer therapy shows promise in early tests
Date:10/26/2011
Delivering anticancer drugs into breast ducts via the nipple is highly effective in animal models of early breast cancer, and has no major side effects in human patients, according to a report by Johns Hopkins Kimmel Cancer Center researchers in Science Translational Medicine on October 26. The results of the study are expected to lead to more advanced clinical trials of so-called intraductal treatment for early breast cancer.
"Our results support the theory that by treating the breast tissue directly we can reach a much more potent drug concentration where it is needed, with far fewer adverse effects on tissues outside the breasts," says oncologist Vered Stearns, M.D., Ph.D., the Breast Cancer Chair in Oncology and co-director of the Breast Cancer Program at the Kimmel Cancer Center, who supervised the clinical part of the study.
"This has been a classic translational medicine collaboration between a bench researcher and a clinician scientist," says cancer biologist Saraswati Sukumar, Ph.D., who supervised the animal tests.
Sukumar, the Barbara B. Rubenstein Professor of Oncology at the Kimmel Cancer Center, and co-director with Stearns of the Breast Cancer Program, began intraductal research more than a decade ago, reasoning that because most breast cancers originate from cells lining the milk ducts, early or preventive therapies should be delivered directly to the ducts via the nipple, rather than intravenously. In 2006, in the journal Cancer Research, Sukumar and her colleagues reported on an initial successful test of the technique using the chemotherapy drug doxorubicin against early ductal breast cancers in rats.
For the current study, Stearns set up a small clinical trial to determine the feasibility of Sukumar's technique in 17 breast cancer patients. Starting first with dextrose -- essentially sugar water -- and later with escalating doses of the same doxorubicin formulation used on Sukumar's rats (pegylated
'/>"/>
| Contact: Vanessa Wasta wasta@jhmi.edu 410-614-2916 Johns Hopkins Medical Institutions Source:Eurekalert |
Related medicine news :
1. Paxil Blocks Tamoxifen, Lowers Survival Odds Against Breast Cancer
2. Low forms of cyclin E reduce breast cancer drugs effectiveness
3. Racial disparities persist in the diagnosis of advanced breast cancer and colon cancer in the U.S.
4. For Some Breast Cancer Patients, Shorter Radiation Works Well
5. Short-term radiation therapy successful on breast cancer
6. Few Women at High Risk for Breast Cancer Take Tamoxifen
7. Hormone May Prevent Aggressive Breast Cancer
8. MSU researcher linking breast cancer patients with alternative therapies
9. MRI May Not Add Value to Routine Breast Cancer Care
10. Breast Cancer Stats Differ Racially Despite Similar Mammogram Rates
11. Businesses Rally Big Efforts to Benefit the Susan G. Komen Phoenix Affiliates Fight Against Breast Cancer
Post Your Comments:
(Date:5/20/2013)... New York (PRWEB) May 20, 2013 National ... Firm P.A. and Thrash Law Firm P.A., both based in ... final approval of the proposed $7.25 billion settlement of a ... transaction fees. The objection was filed Wednesday, May 15, 2013, ... New York. The related lawsuit against Visa and MasterCard (Case ...
(Date:5/20/2013)... is proud to announce the publication of the much-anticipated ... A. Weinberg. , The First Edition has been ... the most important advances in the fast-growing field of ... all of its hallmark features admired by students, instructors, ... of Cancer is a textbook for students studying the ...
(Date:5/20/2013)... 2013 For more than forty years, ... battle against drug and alcohol abuse around the world. ... first guide to help Italian speakers reverse growing trends ... European Monitoring Centre for Drugs and Drug Addiction show ... cannabis in the last year. As a glimpse of ...
(Date:5/20/2013)... -- A child whose mother lived near heavy traffic ... a respiratory infection before the age of 3, a ... nearly 1,300 pairs of mothers and infants from eastern ... their first trimester of pregnancy at some point between ... mothers lived within 100 meters (about 110 yards) from ...
(Date:5/20/2013)... fossa subdural hematoma (PFSDH) is a serious and rare ... with appropriate treatment, there,s an excellent chance of good ... a study in the May issue of ... of Neurological Surgeons . The journal is published by ... Wolters Kluwer Health . , The results support ...
Breaking Medicine News(10 mins):Health News:Parker Waichman LLP Takes on the Credit Card Companies, Fights for Smaller Retailers that Form the U.S. Economy’s ‘Backbone’ 2Health News:Parker Waichman LLP Takes on the Credit Card Companies, Fights for Smaller Retailers that Form the U.S. Economy’s ‘Backbone’ 3Health News:'The Biology of Cancer' by Robert A. Weinberg 2Health News:First Narconon Cannabis Abuse Prevention Guide Takes Aim at Drug Abuse Statistics for Italian Youth 2Health News:Living Near Major Roadways in Pregnancy Tied to Respiratory Woes in Children 2Health News:Study supports 'aggressive' treatment for posterior fossa hematoma in newborns 2Health News:Study supports 'aggressive' treatment for posterior fossa hematoma in newborns 3[0] Parker Waichman LLP Takes on the Credit Card Companies, Fights for Smaller Retailers that Form the U.S. Economy’s ‘Backbone’[0] 'The Biology of Cancer' by Robert A. Weinberg[0] First Narconon Cannabis Abuse Prevention Guide Takes Aim at Drug Abuse Statistics for Italian Youth[0] Living Near Major Roadways in Pregnancy Tied to Respiratory Woes in Children[0] Study supports 'aggressive' treatment for posterior fossa hematoma in newborns
... 11 private healthcare providers into the public NHS system thereby ... sector. //Mr Blair and the health secretary, Patricia Hewitt, welcomed ... to mark the launch of NHS Partners Network. ... towards 'future success' of the NHS. "Wherever people are treated ...
... are at a lesser risk of Parkinson’s, according to ... and Psychiatry. // ,The research team, as ... patients and 106 healthy people, belonging to the same ... sought to throw light on their personality traits and ...
... flu pandemic could claim as much as 140 million ... ,The authors of the report, internationally renowned ... academic Alexandra Sidorenko, estimate that even a mild pandemic ... economy $330 billion in lost production. ,The ...
... in Australia claims to have discovered a novel way ... attention deficit hyperactivity disorder (ADHD). //This novel method, space-age ... space. But it can also be used by the ... , ,Attention deficit hyperactivity disorder (ADHD) is a ...
... firm LG Electronics has said that it will start to ... filter made from using an enzyme contained in the "the ... against the dreaded bird flu virus. ,"We developed ... flu," LG spokeswoman Park Se-won said. The filter was fabricated ...
... are pushing Wal-Mart against a Wall, to cough up more on ... the unions are doing this for the cause of the workers, ... meets the eye. The scene is on the brink of a ... ,The scene at Washington is hotting up with the ...
Cached Medicine News:Blair Welcomes 11 Private Healthcare Providers into NHSAdventure Enthusiasts, Risk Takers and Those Living on the Edge, Good News Coming Your WayBird Flu Could Claim 140 Million Lives: ReportNovel Treatment to Cure People with Learning Disabilities,LG To Market Air Conditioner Capable of Fighting Bird FluUpgrade Health Benefits: Wal-Mart in a Tight Spot
(Date:5/20/2013)... WASHINGTON , May 20, 2013 Medicare ... networks are overwhelmingly satisfied, citing lower costs, convenient ... a new survey from Hart Research Associates released ... More than 40% of Part D seniors (9.5 ... networks. "Seniors like the lower costs, ...
(Date:5/19/2013)... 2013 Whole-cell pertussis vaccines were more effective at ... large recent outbreak, according to a new Kaiser Permanente ... also called DTwP, were available from the 1940s to ... led to the development of acellular pertussis vaccines, which ... the United States had switched from ...
(Date:5/17/2013)... -- The power of plants to cure and rejuvenate, ... depends on the plant kingdom, is the subject of ... Medicine: Healing Plants Around the World, Featuring ... 18 through September 8, 2013. (Photo: ... attractions include a re-creation of the Western world,s oldest ...
Breaking Medicine Technology:Survey: 85% of Part D Seniors in Preferred Pharmacy Plans are Satisfied With Costs, Pharmacy Choices 2Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 2Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 3Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 4Wild Medicine On View at The New York Botanical Garden Through Sept. 8 2... (OTC Bulletin Board: AEMD ), the pioneer ... and cancer, announced today that it has engaged Fabiani ... partnerships that advance biodefense, cancer, and chronic infectious disease ... the first medical device to selectively target the removal ...
... LAIYANG, China, Sept. 30 /PRNewswire-Asia-FirstCall/ -- ... ... ... ,; var first_result; // Results are keyed by longUrl, so we need to grab the first ...
Cached Medicine Technology:Aethlon Medical Engages Fabiani & Company to Advance U.S. Government Partnerships 2Aethlon Medical Engages Fabiani & Company to Advance U.S. Government Partnerships 3Aethlon Medical Engages Fabiani & Company to Advance U.S. Government Partnerships 4Aethlon Medical Engages Fabiani & Company to Advance U.S. Government Partnerships 5Jiangbo Pharmaceuticals Announces Fourth Quarter and Fiscal Year 2010 Results 2Jiangbo Pharmaceuticals Announces Fourth Quarter and Fiscal Year 2010 Results 3Jiangbo Pharmaceuticals Announces Fourth Quarter and Fiscal Year 2010 Results 4Jiangbo Pharmaceuticals Announces Fourth Quarter and Fiscal Year 2010 Results 5Jiangbo Pharmaceuticals Announces Fourth Quarter and Fiscal Year 2010 Results 6Jiangbo Pharmaceuticals Announces Fourth Quarter and Fiscal Year 2010 Results 7Jiangbo Pharmaceuticals Announces Fourth Quarter and Fiscal Year 2010 Results 8Jiangbo Pharmaceuticals Announces Fourth Quarter and Fiscal Year 2010 Results 9Jiangbo Pharmaceuticals Announces Fourth Quarter and Fiscal Year 2010 Results 10Jiangbo Pharmaceuticals Announces Fourth Quarter and Fiscal Year 2010 Results 11Jiangbo Pharmaceuticals Announces Fourth Quarter and Fiscal Year 2010 Results 12Jiangbo Pharmaceuticals Announces Fourth Quarter and Fiscal Year 2010 Results 13Jiangbo Pharmaceuticals Announces Fourth Quarter and Fiscal Year 2010 Results 14Jiangbo Pharmaceuticals Announces Fourth Quarter and Fiscal Year 2010 Results 15Jiangbo Pharmaceuticals Announces Fourth Quarter and Fiscal Year 2010 Results 16Jiangbo Pharmaceuticals Announces Fourth Quarter and Fiscal Year 2010 Results 17Jiangbo Pharmaceuticals Announces Fourth Quarter and Fiscal Year 2010 Results 18Compact, bench-top analyser with minimal water volume requirements and easy waste management....
... source is a superior choice for machine ... headlamps, and dental curing. This is a ... weight, compact and cost competitve with lower ... source utilizes the latest in Cermax technology, ...
... Test System* is a multiplexed, fluorescent, ... multiple assays from a single sample ... a simple and streamlined alternative to ... clinical sensitivity and comparable clinical specificity ...
... 350 Chemistry System offers easy operation, maintenance, and ... STAT, or back-up to the powerful VITROS 5,1 ... the job done right the first time. Its ... are efficient, dependable, and easy-to-use. The VITROS 350 ...
Medicine Products:| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |